Shanghai, China
Shanghai NeuCore/Novribo Pharmaceutical Technology Co., Ltd, established in early 2024 and headquartered at No. 1479 Zhangheng Road, Zhangjiang Hi-Tech Park ，Shanghai, China，is whlolly owned subsidiary of the Shanghai Desano Group， with team of 35 skilled technical professionals. We have successfully delivered over 40 oligonucleotide projects worldwidly, offering services that span siRNA/ASO sequence design, screening, siRNA, ASO, sgRNA synthesis, and process development. By leveraging the synergies within the Desano Group, we provide integrated, one-stop technical service solutions, helping clients accelerate development from early-stage discovery to scalable manufacturing for customers from oligonucleotide industry and institutes.